Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomic biomarkers in coronary artery disease: a narrative review.

Biomarkers in medicine - 1 Mar 2024

Dua Pamila, Seth Sandeep, Prasher Bhavana, Mukerji Mitali, Maulik Subir Kumar, Reeta K H

Abstract excerpt

Coronary artery disease (CAD) has a high mortality rate. Despite various therapeutic targets, non-responsiveness to drugs remains a prevalent issue. Pharmacogenomics assesses the way an individual's genetic attributes affect their likely response to drug therapy. Single-nucleotide polymorphisms play a crucial role in determining these outcomes. This review offers an overview of single-nucleotide polymorphisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Coronary Artery Disease
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 38456296
DOI: 10.2217/bmm-2023-0476

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic biomarkers in coronary artery disease: a narrative review.PMID 38456296Read ↗

Cardiovascular pharmacogenomics: current status and future directions.Semantic proximity Read ↗

Genetic determinants of response to cardiovascular drugs.Semantic proximity Read ↗

Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.Semantic proximity Read ↗

Pharmacogenomics in cardiovascular diseases.Semantic proximity Read ↗

Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.Semantic proximity Read ↗

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).Semantic proximity Read ↗

Emerging genomic applications in coronary artery disease.Semantic proximity Read ↗

Cardiovascular pharmacogenomics.Semantic proximity Read ↗

Cardiovascular drugs and the genetic response.Semantic proximity Read ↗

The Potential of Single Nucleotide Polymorphisms (SNPs) as Biomarkers and Their Association with the Increased Risk of Coronary Heart Disease: A Systematic Review.Semantic proximity Read ↗

Pharmacogenomics in Cardiovascular Diseases.Semantic proximity Read ↗

[Cardiovascular pharmacogenomics].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.